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Abstract 48 
 49 
The scavenger receptor MARCO is expressed in several subsets of naïve tissue resident 50 
macrophages and has been shown to participate in the recognition of various bacterial pathogens. 51 
However, the role of MARCO in antiviral defence is largely unexplored. Here, we investigated 52 
whether MARCO might be involved in the innate sensing of infection with adenovirus and 53 
recombinant adenoviral vectors by macrophages, which elicit vigorous immune responses in vivo. 54 
Using cells derived from mice we show that adenovirus infection is significantly more efficient in 55 
MARCO-positive alveolar macrophages (AMs) and in AM-like primary macrophage lines (MPI 56 
cells) than in MARCO-negative bone marrow-derived macrophages. Using antibodies blocking 57 
ligand binding to MARCO, as well as gene-deficient and MARCO-transfected cells, we show 58 
that MARCO mediates the rapid adenovirus transduction of macrophages. By enhancing 59 
adenovirus infection, MARCO contributes to the efficient innate virus recognition through the 60 
cytoplasmic DNA sensor cGAS. This leads to strong pro-inflammatory responses including the 61 
production of IL-6, IFN-α/β and mature IL-1α. These findings contribute to the understanding of 62 
viral pathogenesis in macrophages and may open new possibilities for the development of tools 63 
to influence the outcome of infection with adenovirus or adenovirus vectors.  64 
 65 
Importance 66 
 67 
Macrophages play crucial roles in inflammation and defense against infection. Several 68 
macrophage subtypes have been identified with differing abilities to respond to infection with 69 
both natural adenoviruses as well as recombinant adenoviral vectors. Adenoviruses are important 70 
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respiratory pathogens, which elicit vigorous innate responses in vitro and in vivo. The cell surface 71 
receptors mediating macrophage type specific adenovirus sensing are largely unknown. 72 
The scavenger receptor MARCO is expressed on some subsets of naïve tissue resident 73 
macrophages, including lung alveolar macrophages. Its role in antiviral macrophage responses is 74 
largely unexplored. Here, we studied whether the differential expression of MARCO might 75 
contribute to the varying susceptibility of macrophage subtypes to adenovirus.  76 
We demonstrate that MARCO significantly enhances adenovirus infection and innate responses 77 
in macrophages. These results help to understand adenoviral pathogenesis and may open new 78 
possibilities to influence the outcome of infection with adenoviruses or adenovirus vectors.	   	  79 
 5 
Introduction 80 
 81 
Virus – macrophage interactions play crucial roles in the pathogenesis and control of viral 82 
infections. Since intracellular pathogen sensing is central in the elicitation of early antiviral 83 
responses, early interactions of viral pathogens with innate immune cells, including macrophages, 84 
contribute significantly to effective antiviral defence mechanisms (1, 2). Macrophages differ in 85 
their origin, development and function (3). Since viruses use a range of surface molecules as 86 
receptors and facilitators for cellular entry (4), cell surface heterogeneity in macrophage subsets 87 
is expected to influence pathogen entry and also the innate stimulatory activity of different virus 88 
types. 89 
Adenoviruses (Ad) are important, non-enveloped, double stranded DNA-containing pathogens. 90 
Replication-defective recombinant Ad vectors are used as vectors for vaccination against 91 
infectious diseases, for cancer immunotherapy and for studies of virus-host cell interactions (5, 92 
6). Human Ad species C members (e.g. Ad type 2 and 5) are important tools in such applications 93 
(7, 8). Adenovirus infection elicits potent innate immune responses in vitro and in vivo and 94 
mononuclear phagocytes are major contributors to these responses (9). Different populations of 95 
tissue macrophages and dendritic cells produce high levels of pro-inflammatory cytokines and 96 
type I interferons in response to Ad particles. These responses can critically influence the course 97 
of natural Ad infection or the outcome of Ad vector applications, for example by tuning the 98 
expression of cell surface receptors on epithelial cells (10).  99 
Virus entry triggers signaling pathways which play key roles in Ad-elicited pro-inflammatory 100 
responses but the contribution of cellular factors that mediate Ad entry into resident tissue 101 
macrophages, such as surface receptors, are incompletely understood (11, 12). The Coxsackie-102 
Adenovirus receptor (CAR) and integrins are main surface receptors for Ad entry in epithelial 103 
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cells. In vitro studies have shown that Ads attach to these cells by the interaction of the viral fiber 104 
knob with CAR leading to the exposure of the membrane lytic protein-VI (13). Viruses are 105 
subsequently internalized via receptor mediated endocytosis, escape to the cytosol and import 106 
viral DNA into the nucleus (12, 14–17). In liver cells in vivo, Ad particles can also be 107 
internalized via binding to cell membrane heparan sulfate proteoglycans through blood factors 108 
(18, 19).  109 
While macrophages and other myeloid cells do not express CAR, interactions with other host 110 
 factors have been shown to contribute to Ad entry in these cells. This includes opsonization by 111 
 serum factors such as antibodies or complement, leading to viral entry into macrophages and  112 
neutrophils via ubiquitously expressed Fc and complement receptors (20, 21). Contributions to 113 
 virus entry by serum lactoferrin and the coagulation factor X have also been reported (19, 22). 	  114 
Furthermore, the scavenger receptors (SR) SR-A and SREC-I, members of pattern recognition 115 
receptors with broad ligand specificity and expressed ubiquitously on macrophages, have been 116 
implicated to play a role in Ad uptake in macrophages (21–25). 117 
Several sensors have been implicated in the innate activation of mononuclear phagocytes by Ads.  118 
Toll Like Receptors (TLR) 2, 4 and 9 have been shown to contribute to Ad induced cytokine 119 
production (26, 27). Efficient triggering of innate responses was shown to require endosomal 120 
escape and cytoplasmic detection of the virus (28).  Recently, the cyclic GMP-AMP synthase 121 
(cGAS) has been identified as a major cytosolic innate sensor for Ads (29, 30).  122 
Previously, we have demonstrated that the production of innate cytokines to respiratory 123 
pathogens, including Ads, is significantly stronger in murine AMs and in non-transformed, GM-124 
CSF-dependent, self-renewing AM-like macrophages (designated Max-Planck-Institute (MPI) 125 
cells) than in bone marrow derived macrophages (BMMs) (31). Similar to AMs, MPI cells 126 
express high levels of the SR class A protein MARCO while the rather Ad insensitive BMMs do 127 
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not express this scavenger receptor. Functionally, MARCO has been shown to directly enhance 128 
antibacterial macrophage responses (32). Whether it plays a similar role in macrophage responses 129 
to viral infections has not yet been investigated. 130 
In this study, we investigated the possibility that MARCO expression enhances the susceptibility 131 
of macrophages to Ad. Using several mouse macrophage types, we show that the presence of 132 
MARCO allows rapid adenovirus gene expression and strong virus-stimulated innate responses, 133 
while blocking or the lack of MARCO, results in a strong impairment of these processes. Thus, 134 
MARCO is involved in innate Ad recognition and the elevated Ad sensitivity of MARCO-135 
expressing macrophages is due to the expression of this receptor on the cell surface.  136 
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Results 137 
 138 
Ad entry and the activation of innate signaling in MPI cells and AMs, unlike that in BMMs, 139 
is fast and efficient  140 
Intracellular sensing of incoming virus particles is a major process in triggering antiviral 141 
responses. We tested the efficiency of adenoviral transduction of various macrophage types, i.e. 142 
alveolar macrophages (AMs), bone marrow-derived macrophages (BMMs) and MPI cells, using 143 
a non-replicating GFP-expressing adenovirus. The lung epithelial cell line A549 that can be 144 
infected efficiently with Ads was also used as a positive control. Microscopic examination of the 145 
cells 16 h post infection (p. i.) infection revealed that the majority of the MPI cells, AMs and 146 
A549 cells were strongly GFP positive, while BMMs expressed GFP only weakly (Fig. 1A). The 147 
time course of GFP expression in infected cells was analyzed by flow cytometry and showed that 148 
in A549, MPI cells and AMs GFP expression was detectable already 6h after infection, whereas 149 
at 10 h after infection, BMMs were still GFP negative (Fig. 1B). After 16 h, about 94 - 96 % of 150 
the A549, MPI cells and AMs expressed GFP. In MPI cells and AMs two populations, a 151 
moderately and a strongly positive subset could be identified. In contrast, only 75% of BMMs 152 
were weakly GFP-positive by this late time-point. These results demonstrated a faster and more 153 
efficient transduction of MPI cells and AMs compared to BMMs.  154 
To compare the kinetics and strength of the Ad-induced signaling and cytokine responses in the 155 
different macrophage types, we measured the activation of the transcription factors IRF3 and NF-156 
κB, the activation of the mitogen-activated protein kinase p38, and the secretion of IFN-α/β and 157 
IL-6 at various time points after Ad inoculation. Activation of p38 and IRF3 was analyzed using 158 
phospho-specific antibodies whereas nuclear translocation of the NF-κB subunit p65 was used to 159 
analyze NF-κB activation. In MPI cells, the strong activation of p38, IRF3 and NF-κB was first 160 
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detectable 1-2 h after infection, and persisted up to 8 h for NF-κB and at least up to 10 h for IRF3 161 
and p38 (Fig. 2A). In contrast, in BMMs a weak, delayed and shorter activation of p38 was 162 
detected between 2 and 6 h and the activation of IRF3 and NF-κB was not detected at all (Fig. 163 
2A). Consistent with this, Ad-infected MPI cells exhibited an early and strong production of type 164 
I interferon and IL-6, while only marginal production of these cytokines was observed 16 h after 165 
inoculation of BMMs (Fig. 2B). Murine AMs (Siglec F, F4/80 and CD11c triple positive cells), 166 
which constitute the vast majority of freshly isolated BAL cells (Fig. S1A), were also infected 167 
with Ad. Similar to the infection of MPI cells, and unlike that of BMMs, they exhibited early and 168 
strong phosphorylation of p38 and IRF3 (Fig. S1B) and a strong cytokine response (Fig. S1C).  169 
In summary, these results document a large difference in the activation of Ad-stimulated innate 170 
signaling between MPI cells/AMs and BMMs, and this correlates with the efficiency of Ad 171 
transduction.  172 
 173 
Cytoplasmic sensing by the cyclic GMP-AMP synthase (cGAS) mediates Ad-stimulated 174 
innate responses in MPI cells 175 
The initiation of Ad-induced innate responses has been attributed to the cell surface receptors 176 
TLR2 and 4, the endosomal TLR9, and more recently to the cytoplasmic DNA sensor cGAS (26, 177 
27, 29). MPI cells deficient for both TLR2 and TLR4 showed no reduction of IL-6 production 178 
following Ad infection (Fig. 3A). Furthermore, infection of MPI cells with the Ad2 ts1 mutant 179 
virus, which is taken up into endosomes but does not enter the cytosol (33), did not induce 180 
detectable cytokine production (Fig. 3A), indicating that virus sensing at the plasma membrane or 181 
in the endosomes is not sufficient for the induction of the innate responses in MPI cells. To test 182 
the role of cytoplasmic cGAS, we used shRNA to knockdown this sensor in MPI cells. A C911 183 
mismatch shRNA was used as a control (34). AdGFP transduction of cGAS knock-down cells 184 
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resulted in significantly decreased cytokine production compared to Ad-transduced MPI cells 185 
expressing a the C911 control shRNA (Fig. 3B). In a control experiment, cytokine production in 186 
response to LPS was not reduced in cGAS knock-down MPI cells (Fig. S2A). Notably, the 187 
knockdown of cGAS had no negative influence on the AdGFP transduction of MPI cells as 188 
measured by GFP expression in infected MPI cells (Fig. S2B). 189 
 190 
Ad induced production of mature IL-1α  in MPI cells, but not in BMMs 191 
We have previously demonstrated that LPS-stimulated MPI macrophages, unlike BMMs, secrete 192 
substantial amounts of IL-1α (31). Ad infection also induced a significant IL-1α response, which 193 
peaked 8 h after inoculation, and a marginal IL-1β response in MPI cells, but not in BMMs (Fig. 194 
4A). We tested whether Ad infection also induces the maturation of these cytokines. For this 195 
purpose, we infected MPI cells and BMMs with Ad, and analyzed the IL-1α and IL-1β forms in 196 
cell lysates at different times p. i. by Western blotting. Ad infection resulted in the processing of 197 
pre-existing immature IL-1α between 0.5 and 8 h p. i. and in the accumulation of pro-IL-1α, 198 
starting after 4 h of stimulation (Fig. 4B). Furthermore, immature IL-1β, but not the mature IL-1β 199 
form was induced in Ad-infected MPI cells at later time points (4-16 h. p.i.) (Fig. 4B). Finally, no 200 
induction of IL-1α or IL-1β was detectable in lysates of Ad-infected BMMs.  201 
 202 
Blocking the scavenger receptor MARCO on MPI cells and AMs interferes with Ad entry 203 
and the induction of cytokine production.   204 
We investigated whether the differential expression of a ligand recognition receptor might be 205 
responsible for the increased sensitivity of MPI cells and AMs to Ad compared to BMMs. As 206 
expected, the mRNA for CAR, the main receptor responsible for the uptake of species C Ads in 207 
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most non-immune cells, is not detectable in MPI cells and BMMs (Fig. S3A, B).  Although the 208 
scavenger receptors SR-A and SREC1 have been implicated in Ad entry in macrophages (21–25), 209 
analysis of mRNA levels in MPI cells and BMMs did not show a strong expression of these 210 
genes in MPI cells (Fig. S3A, B), in agreement with our previously obtained microarray data 211 
(31). This suggested that these proteins are not involved in the differential sensitivity to Ad (Fig. 212 
S3). As shown in Fig. S3A-C and demonstrated previously (31, 35), another related microbial 213 
sensor, the scavenger receptor MARCO, is highly expressed in MPI cells, but absent in resting 214 
BMMs. SR-A is weakly expressed on both cell types (Fig. S3C). We also tested MARCO 215 
expression on various tissue resident macrophages.  We found no significant MARCO expression 216 
in liver and skin macrophages. However, peritoneal macrophages, AMs and spleen marginal zone 217 
macrophages exhibited substantial levels of MARCO on their surface (Fig. S4).  These cell types 218 
have previously been reported to be very efficiently infected by Ads (36–39). We tested a 219 
possible involvement of MARCO in the Ad transduction and in the elicitation of innate 220 
responses. For this purpose, we compared GFP expression and IL-1α and IL-6 responses of 221 
AdGFP-infected MPI cells and AMs in the presence or absence of a monoclonal antibody that 222 
blocks ligand binding to MARCO (40). Pre-incubation for 30 minutes with anti-MARCO, but not 223 
with a control antibody, almost completely abolished both the AdGFP transduction and the virus 224 
induced cytokine responses of these cell types (Fig. 5A, B). These results suggested a crucial role 225 
for MARCO in the Ad sensing in MPI cells and AMs.   226 
Several serum proteins have been shown to mediate Ad uptake to myeloid cells previously (20, 227 
22), however, scavenger receptors mediate ligand internalization without their help (32). So far, 228 
the Ad transduction of macrophages in this study was carried out in the presence of fetal calf 229 
serum.  As shown in Fig. 5C, the absence of fetal calf serum did not reduce the GFP expression 230 
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(upper panel) or the IL-6 response (lower panel) of the infected cells. These results suggest that 231 
MARCO-expressing macrophages do not need opsonizing proteins to sense Ads. 232 
 233 
MARCO deficiency drastically reduces the Ad transduction rate and the reactivity of MPI 234 
cells and AMs to the virus 235 
To test the importance of MARCO for Ad transduction, we generated an MPI macrophage line 236 
from MARCO-/- mice. As expected, these cells expressed macrophage markers and responded to 237 
LPS (TLR4 ligand) and FSL-1 (TLR2 ligand) similarly as wt MPI cells (Fig. S5A, B). 238 
Importantly however; compared to wt MPI macrophages, MARCO-/- cells showed a strong 239 
reduction of Ad transduction (Fig. 6A, C) and Ad stimulated cytokine responses (Fig. 6B), while 240 
the Ad infection of MARCO deficient BMMs was not significantly reduced (Fig 6C). A similar 241 
Ad-insensitive phenotype was also exhibited by two other MARCO-/- MPI cell lines, generated 242 
independently (not shown). In addition, we isolated AMs from wt, MARCO-/-, SR-A-/- and 243 
MARCO-/-/ SR-A-/- double deficient mice and infected them with AdGFP. Compared to wt cells, 244 
MARCO-/- and MARCO-/-/SR-A-/- AMs showed strongly reduced GFP expression (Fig. 6D) and 245 
lacked an IL-6 response (Fig. 6E). However, the loss of SR-A alone resulted in no reduction of 246 
GFP expression and only a moderate decrease of the IL-6 response in infected AMs (Fig. 6E). As 247 
expected, the expression of macrophage surface markers and the LPS responses of wt and 248 
MARCO-/- AMs were very similar (Fig. S5C, D).  We also tested if MARCO expression 249 
contributes to Ad infection in peritoneal macrophages. We found that wt cells can be efficiently 250 
infected and activated (IL-6 response) by AdGFP; however, MARCO deficiency resulted in the 251 
marked reduction of AdGFP transduction and of virus triggered IL-6 response (Fig. 7).  These 252 
results indicate that the absence of MARCO, but not SR-A, severely reduces Ad transduction and 253 
the innate responses in these macrophage types. 254 
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 255 
Transfection of MARCO in macrophages leads to increased Ad sensitivity  256 
To provide further evidence for the importance of MARCO, we transfected the murine RAW 257 
264.7 macrophage line that does not express MARCO (Fig. S6A, right) with a plasmid 258 
expressing the full length murine MARCO, or with the same expression vector lacking MARCO. 259 
In both cases, expression of the co-transfected reporter tomato gene allowed the discrimination 260 
between transfected (tomato positive) and non-transfected (tomato negative) cells. As shown in 261 
Fig. 8A, both transfections yielded approximately 33% tomato positive cells at the time of 262 
analysis. Transfection of RAW 264.7 cells with the MARCO-expressing plasmid resulted in 263 
MARCO surface expression only in tomato-positive cells (Fig. S6A, left). MARCO was absent in 264 
both tomato-positive and -negative cells transfected with the control plasmid, (Fig. S6A, left). 265 
MARCO- and control-transfected cells were infected with AdGFP and analyzed 8 hours post 266 
inoculation for GFP and tomato expression by flow cytometry. While 50 % of the MARCO-267 
transfected, tomato-positive cells expressed GFP, less than 10 % of control-transfected, tomato-268 
positive cells expressed GFP, indicating a dramatic increase of Ad transduction due to the 269 
expression of MARCO. Pearson´s data analysis revealed a moderate positive correlation (r=0.34; 270 
P<0.0001) of GFP and tomato expression in MARCO transfected RAW264.7 cells, whereas no 271 
significant correlation (r=-0.02; P=0.3361) was found for the control transfected cells (Fig. S6B). 272 
Furthermore, only cultures containing the MARCO-transfected cells produced high levels of IL-6 273 
in response to AdGFP (Fig. 8B).  274 
 14 
Discussion 275 
 276 
In the present study, we show that when compared to BMMs, Ad infects mouse alveolar 277 
macrophages and the alveolar macrophage-like MPI cells significantly more strongly and with an 278 
accelerated kinetics. This higher infectivity rate explains why the Ad-induced pro-inflammatory 279 
cytokine responses in the two latter macrophage types are substantially higher than in BMMs. 280 
Previous studies indicated the possible involvement of cell surface TLR2, 4, endosomal TLR9 281 
and non-TLR cytosolic virus sensing in the Ad stimulated innate cytokine responses (26–28). 282 
Using gene-deficient cells and the endosomal penetration-defective mutant virus Ad2 ts1, we 283 
excluded a significant involvement of TLR2, 4 and of endosomal sensing in the Ad-triggered 284 
responses of MPI cells. Earlier, we showed that the IFN-α/β and IL-6 responses elicited by Ad 285 
strictly require viral endosomal escape (28). Here, we show that Ad transduction is much more 286 
efficient in MPI cells and AMs than in BMMs. This implies that both the delivery of viral 287 
particles to the cytosol and the nuclear import of viral DNA are efficient in these cells. Since 288 
incoming viral DNA is frequently and to a high level mis-delivered to the cytosol (17), these 289 
results explain why the triggering of innate signalling, such as the activation of NF-κB, IRF-3 290 
and p38, and the induction of cytokine responses are faster and stronger in AMs and MPI cells 291 
than in BMMs. The use of a different, less efficient Ad internalisation route in BMM may be 292 
responsible for the lack of detectability of NF-κB and IRF-3 activation upon infection and 293 
therefore for a very weak cytokine response. This is consistent with our previous results, and 294 
results of others, showing that significantly higher Ad doses are necessary to elicit potent 295 
cytokine responses in BMMs (28, 41).    296 
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The finding that Ad ts1, a virus mutant unable to enter the cytosol does not induce an IL-6 297 
response in MPI cells confirms that Ad-triggered responses need cytosolic virus sensing. We 298 
show here that the knockdown of the cytosolic DNA sensor cGAS impairs the ability of Ads to 299 
activate MPI cells, but does not affect adenoviral transduction measured by GFP transgene 300 
expression. These findings are in agreement with the major role of cytoplasmic virus sensing in 301 
MPI cells and with recent data showing that cGAS is a dominant Ad sensor for the induction of 302 
IFN-αβ, but not for the nuclear translocation of the viral DNA in murine MS1 and RAW 264.7 303 
cell lines (29). 304 
A likely explanation for the considerable differences in the kinetics of transduction between AMs 305 
and MPI cells and those in BMMs was the differential expression of a specific cell surface 306 
receptor. The scavenger receptor MARCO, which is highly expressed in alveolar, peritoneal and 307 
MPI macrophages but not in BMMs (31) appeared to be a suitable candidate. Indeed, our data 308 
demonstrate that the loss of function of MARCO, achieved either by MARCO-blocking 309 
antibodies or by MARCO knockout in AMs and MPI macrophages, both lead to severely reduced 310 
expression of Ad-transduced GFP and Ad-induced cytokine production. Moreover, the 311 
introduction of MARCO into RAW 264.7 macrophages, which do not express this protein, 312 
rendered the cells susceptible to Ad transduction and contributed to increased cytokine 313 
production. Thus, MARCO is decisively involved in the susceptibility of macrophages to Ad. 314 
In the past, MARCO was shown to mediate the direct binding and internalization of various non-315 
opsonized particles. Antibodies to the ligand-binding domain of this receptor can block the 316 
interaction (35). In agreement, our data obtained with MPI cells reveal that Ad infection and the 317 
elicitation of innate responses by Ad does not require the presence of serum but can be inhibited 318 
by the MARCO blocking antibody. Therefore, it is likely that MARCO, similar to its role in the 319 
 16 
uptake of other microbial and non-microbial agents, mediates the internalization of adenovirus 320 
and thus promotes subsequent innate responses.  This may occur in cooperation with 321 
other plasma membrane proteins. A cooperative action of the Ad receptor CAR with integrins has 322 
been shown previously to initiate viral entry in epithelial cells (13). Tissue resident macrophages 323 
are very heterogeneous (3) and variable expression of the factors responsible for Ad uptake and 324 
transduction, including MARCO, may explain the observed wide range of Ad infectibility of the 325 
polyclonal MPI cells, AMs and peritoneal macrophages. 326 
SR-A, a scavenger receptor related to MARCO and commonly expressed in various macrophage 327 
types, has been reported to be involved in the uptake of Ad by macrophages (21–25). Here, the 328 
comparison of GFP expression and cytokine production in AdGFP-infected alveolar 329 
macrophages from wt, MARCO-/-, SR-A-/- and MARCO-/-/SR-A-/- mice indicated that this 330 
receptor, either alone or in combination with MARCO, does not play a major role in the Ad 331 
infection or activation of this macrophage type.  332 
The identification of MARCO involvement in the susceptibility of cells to Ad agrees well with 333 
previous studies demonstrating that AMs and splenic marginal zone macrophages, which strongly 334 
express MARCO, trap Ad particles very early after infection (36, 39).  335 
Ad induced in vivo IL-1α production has been demonstrated previously in spleen. Di Paolo et al. 336 
showed that MARCO-positive spleen marginal zone macrophages are a source of IL-1α in Ad 337 
infected mice (36). They have also shown Ad stimulated, IL-1α-mediated biological responses 338 
and the nuclear translocation of IL-1α. However, proteolytic maturation of this cytokine has not 339 
been demonstrated because similar to the N-terminal pro-piece ppIL-1α, the immature IL-1α 340 
precursor can also readily translocate into the nucleus (42). As shown previously (31) and in the 341 
present study, MARCO-expressing AMs and MPI cells also exhibit a robust IL-1α response upon 342 
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infection with Ads. We provide direct evidence for the intracellular processing of IL-1α in Ad-343 
infected MPI cells. Both the full length and the processed IL-1α forms are biologically active, 344 
although the pro-inflammatory activity of the mature IL-1α protein is higher (43). Since Ads are 345 
important respiratory pathogens (44), and IL-1α has been shown to play a central role in lung 346 
pathologies induced by several microbial agents (45, 46), the elucidation of the mechanisms of 347 
Ad-induced IL-1α production in lung alveolar macrophages is likely to have medical 348 
significance.  Previously, di Paolo et al. (37) demonstrated that Il-1α produced by MARCO-349 
expressing splenic marginal zone macrophages is responsible for splenic neutrophil recruitment 350 
and the subsequent elimination of virus-infected cells. Thus, similar mechanisms may contribute 351 
to the AM-mediated control of respiratory Ad infection. 352 
While MARCO is known to be involved in the innate sensing of various bacteria, much less is 353 
known about its role in virus infection and antiviral defence. Recently, MARCO was shown to 354 
play a role in the entry of HSV and vaccinia viruses into keratinocytes but macrophage infection 355 
and antiviral innate responses were not investigated (47, 48). MARCO was also shown to 356 
indirectly suppress early antiviral responses by removing cellular debris in the course of influenza 357 
infection (49). In contrast, our studies demonstrate a positive role for MARCO in the direct 358 
mediation of virus infection and triggering of antiviral responses in macrophages. Thus, MARCO 359 
may influence antiviral innate responses in a virus type specific manner. 360 
The expression of MARCO in specific subsets of naïve tissue resident macrophages can be 361 
important for the primary sensing of naturally occurring viral infections. AMs represent an early 362 
line of defense against respiratory pathogens; thus, the mechanisms shown here may critically 363 
influence the early stages of natural adenovirus infection. In addition, MARCO expression can be 364 
induced by inflammatory stimuli in macrophages normally not expressing this receptor (50). This 365 
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may broaden the macrophage types contributing to the clearance of viral pathogens during the 366 
later phases of infection. 367 
Our findings imply potential beneficial and harmful effects in medical applications using 368 
recombinant adenoviruses. MARCO-mediated Ad infection of mononuclear phagocytes could 369 
contribute directly to efficient antigen processing and presentation. The cytokine responses 370 
induced by the vector could also provide adjuvant effects for vaccination. However, MARCO 371 
mediated innate responses may be damaging, if the inflammatory response is too strong. 372 
Furthermore, certain MARCO sensed pathogens, such as Ad and mycobacteria, induce 373 
hypersensitivity to LPS and to other TLR ligands (51–53). Exposure of hypersensitive 374 
individuals to TLR-triggering pathogens may lead to uncontrolled inflammatory reactions and in 375 
the worst case to septic shock and death (54).  376 
Our findings present a new target for further analyses of Ad-macrophage interactions. Future 377 
studies delineating the details of the Ad-MARCO interaction may provide tools to beneficially 378 
influence both naturally occurring Ad infections as well as therapeutic approaches utilizing this 379 
viral vector.   380 
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Materials & Methods 381 
 382 
Mouse Strains. C57BL/6 (wt) and C57BL/6 MARCO-/- , C57BL/6  SR-A-/- and C57BL/6 383 
MARCO-/-/SR-A-/- mice (50) were bred under specific pathogen-free conditions at the Max-384 
Planck Institute Freiburg or at the University Hospital Rheinisch-Westfälische Technische 385 
Hochschule Aachen. Knock-out mice strains were originally provided to S.G. by K. Tryggvason, 386 
Karolinska Institute, Stockholm, Sweden.  Procedures were in accordance with institutional, state 387 
and federal guidelines on animal welfare.  388 
Cell culture, Adenovirus infection and MARCO blocking. Murine AMs were isolated by 389 
bronchoalveolar lavage, and BMMs and fetal liver-derived MPI cells were generated as described 390 
(31). Murine peritoneal cells were obtained by lavage with 5 ml PBS. Murine spleen cell 391 
suspensions were obtained by mechanical disintegration. To obtain skin cells, mouse ears were 392 
digested with Liberase TM (Roche) as described in (55). Minced mouse livers were digested with 393 
Liberase TM (Roche) for 30 min at 37°C and Kupffer cells were further enriched by gradient 394 
centrifugation, as described in (56). The A549 adenocarcinoma derived human alveolar basal 395 
epithelial cells and RAW 264.7 murine macrophages were cultured in DMEM (Gibco) 396 
supplemented with 10% FCS (Biochrom), 100 µg/ml streptomycin (Gibco), 100 U/ml penicillin 397 
(Gibco) and 10 mM HEPES (Gibco). For the induction of cytokines, all cell types were used at a 398 
density of 5 x 105 cells/ml and plated on 96-well microtiter plates (Nunc) or 6-well plates (Nunc). 399 
For adenovirus infection, the replication-deficient green fluorescent protein-expressing species C 400 
human Ad5 virus (AdGFP), the species C human wt Ad2 or the mutant Ad2 ts1 were used. All 401 
viruses were used at a concentration of 1000 particles/cell if not stated otherwise. GFP 402 
transduction was assessed using fluorescence and phase contrast microscopy or FACS. The 403 
viruses were propagated and purified with CsCl2 density gradient ultracentrifugation as described 404 
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(57). The concentration of virus particles was determined using a spectrophotometer. OD 405 
260−OD 330=1 corresponds to 10 12 virus particles/ml and the ratio of viral particles to plaque 406 
forming units was 20:1. 407 
LPS from S. minnesota R595 (Enzo life sciences) was used at a concentration of 100 ng/ml.  408 
MARCO ligand binding was blocked by incubation of cells with purified anti-mouse MARCO 409 
antibody (clone ED31, AbD Serotec) at a concentration of 20 ng/µl for 30 minutes prior to 410 
AdGFP infection. A purified rat anti-mouse IL-4 (clone 11B11, BD Biosciences) was used as an 411 
isotype control.  412 
shRNA-mediated knockdown of cGAS in retrovirus transduced MPI cells. The following 413 
plasmids were generously provided by Eric Campeau (pENTRpTER+ Addgene plasmid #17453, 414 
pCQXIN X2 DEST Addgene plasmid #17399) and a published protocol was followed (58). Viral 415 
RNAi for  mcGAS, and its C911 control, were established as described (34). The following 416 
oligos were designed using the Invitrogen shRNA block-it tool (Life Technologies) and 417 
purchased from Microsynth Switzerland: mcGAS (adapted from (59)):  418 
mshcGAS_for 5’GATCCCGGATTGAGCTACAAGAATAGTGTGCTGTCCTATTCTTGT 419 
AGCTCAATCCTTTTTGGAAA-3’, mshcGAS_rev 5’AGCTTTTCCAAAAAGGATTGAG 420 
CTACAAGAATAGGACAGCACACTATTCTTGTAGCTCAATCCGG-3’, mshcGAS_ 421 
C911_for 5’-GATCCCGGATTGAGGATCAAGAATAGTGTGCTGTCCTATTCTTGATC 422 
CTCAATCCTTTTTGGAAA-3’, mshcGAS_C911_rev 5’AGCTTTTCCAAAAAGGATTGA 423 
GGATCAAGAATAGGACAGCACACTATTCTTGATCCTCAATCCGG-3’.  424 
shRNAs were cloned into the entry vector pENTRpTER+ and recombined into the MMLV-425 
destination vector pCQXIN X2 DEST using Gateway cloning with LR clonase. Plasmids were 426 
validated by sequencing. VSV-G-pseudotyped MLV retroviruses were generated according to 427 
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standard procedure in HEK 293T cells and used to produce stably transduced MPI cells using 428 
G418 selection. Knockdown efficiency was 80%. 429 
FACS analysis. Nonspecific binding was blocked by pre-incubation of the cells with anti-430 
CD16/CD32 antibody (93, BioLegend) in 1% goat serum in PBS. MARCO was detected with 431 
purified mouse MARCO antibody (ED31, AbD Serotec) in combination with Alexa Fluor 647-432 
conjugated goat anti-rat IgG (Molecular Probes). Fluorophore-conjugated CD11b (M1/70) and 433 
CD14 (Sa14-2), CD11c (N418), F4/80 (BM8), CD45 (30-F11), antibodies were from BioLegend, 434 
Siglec F (E50-2440) from BD Biosciences, SignR1 (ERTR9) and SR-A (2F8) from AbD Serotec. 435 
Data were acquired on a BD FACSCanto II cytometer and analyzed with FlowJo software (Tree 436 
Star). 437 
Western blotting. Cell lysates were prepared in the presence of phosphatase inhibitor mixture II 438 
(Sigma), protease inhibitor cocktail (Sigma) and PMSF (Sigma) using 100 µl of the respective 439 
lysis buffer per 106 cells. RIPA buffer (20 mM TRIS pH 7.5, 150 mM NaCl, 1 % NP40, 0,5 % 440 
DOC, 1 mM EDTA, 0,1 % SDS) was used to prepare whole cell lysates or the cells were 441 
fractionated for cytosolic and nuclear fractions as described (31).  The quality of fractionation 442 
was checked using anti-GAPDH (6C5, Acris Antibodies) and polyclonal rabbit anti-histone 3 443 
antibodies (Merck Millipore) as described previously (31). Protein samples were blotted to 444 
nitrocellulose membranes after denaturing SDS-polyacrylamide gel electrophoresis. The 445 
following antibodies were used for immunoblotting: rabbit anti-NFkB p65 (C-20, Santa Cruz 446 
Biotechnology), rabbit anti-phospho-IRF3 (Ser396)(4D4G, Cell Signaling Technology), rabbit 447 
anti-phospho-p38 MAPK (Thr180/Tyr182) (12F8, Cell Signaling Technology), polyclonal goat 448 
anti-IL-1α (R&D Systems), hamster anti-IL-1α (ALF-161, Santa Cruz Biotechnology), hamster 449 
anti-IL-1β (B122, RD Systems) horseradish peroxidase-conjugated goat anti-mouse and goat 450 
anti-rabbit IgG (both Cell Signaling Technology), mouse anti-hamster IgG (Santa Cruz 451 
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Biotechnology) and rabbit anti-goat IgG (Jackson Immunoresearch). Blots were developed with 452 
the SuperSignal West Pico Chemiluminescent Substrate (Thermo Scientific).  453 
Cytokine detection. IL-6, IL-1α and IL-1β were quantified in cell free culture supernatants by 454 
ELISA using antibody pairs from BD Pharmingen (IL-6, IL-1β) and Ebioscience (IL-1alpha) 455 
according to the instructions of the manufacturer. IFN-α/β was measured with reference to a 456 
recombinant mouse IFN-β standard using an established luciferase expression based bioassay as 457 
described (28). 458 
Transfection. The mammalian expression vector pCmarcoiT was used to express the full length 459 
murine MARCO protein. To construct the vector, full length MARCO cDNA was amplified from 460 
MPI cell cDNA using the forward primer 5'-gccatgggaagtaaacaactcc-3' and the reverse primer 5'-461 
gtcaggagcattccacacccgca-3’ and cloned to give a CMV-driven bicistronic transcript with the 462 
tandem-dimer Tomato gene (henceforth referred to as tomato) expressed from an internal 463 
translation initiation site. This allows FACS identification and analysis of the transfected cells. 464 
RAW 264.7 cells were transfected using TurboFect Transfection Reagent (Thermo Scientific) 465 
according to manufacturer’s instructions.  466 
Quantitative RT-PCR. RNA was prepared using Tri reagent (Sigma) according to the 467 
manufacturer’s instructions. SuperScript II Reverse Transcriptase (Invitrogen) was used to 468 
reverse-transcribe 2 µg of RNA. Real-time RT–PCR was performed using LightCycler® 480 469 
SYBR Green I Master kit (Roche) and the Roche LightCycler 480 instrument with the following 470 
primers: Marco: fw: 5’-ACCAGGCCTACCAGGTTTG- 3’, rev: 5’-471 
ACCCTGCACTCCAGGTTTT- 3’; Sra: fw: 5’-CAGTCAGCATCCTCTTGTTCA- 3’, rev: 5’-472 
GTCTTCTTTACCAGCAATGACAAA- 3’; Srec1: fw: 5’-GACTGGACCCGAAGGACA- 3’, 473 
rev: 5’-CGAGCCCAAGTTGGTGAG- 3’; CAR: fw: 5’- CCCTGGGGTTGCAAATAAG- 3’, 474 
rev: 5’- GATCCATCCACGAAGCATCT- 3’; Actin: fw: 5’-475 
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GTCCACACCCGCCACCAGTTCG- 3,’ rev: 5’-GGAATACAGCCCGGGGAGCATCGTC- 3’. 476 
Data was normalized to β-actin expression and plotted on a relative scale for each gene by setting 477 
the cells with the highest level of expression to 100 %. 478 
Data analysis, Pearson correlation and statistics. Data were analyzed with Graphpad Prism 5.0 479 
software. Data are represented as mean and error bars show the standard error of the mean. 480 
Statistical significance was calculated using the unpaired t-test (*: P <0.05; **: P < 0.01; ***: P< 481 
0.001). If not stated otherwise, the figures show representative results of at least 3 independent 482 
experiments.   483 
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Figure legends 671 
 672 
FIG 1. Efficiency of Ad infection in different cell types. (A) GFP expression was analyzed in 673 
different cell types 16 h after infection with AdGFP using fluorescence (top) and light (phase 674 
contrast; bottom) microscopy. Bars indicate 50 µm. (B) FACS analysis of GFP expression in 675 
infected cells at the indicated time points. The number indicates the frequency of GFP+ cells 16 h 676 
after infection, the gate indicates GFP+ cells.  677 
FIG 2. Early immune activation of MPI cells and BMMs after infection with AdGFP. (A) 678 
Western blot analysis of the cytoplasmic (p-p38, p-IRF3) or nuclear (NF-kB p65) cell fractions at 679 
the indicated time points. (B) Cytokine production was measured by ELISA in cell free 680 
supernatants at the indicated time points. 681 
FIG 3. Ad-induced cytokine production in MPI cells is independent of TLR2/4 but dependent on 682 
cGAS. (A) IL-6 induction in wt and TLR2/4-/- MPI cells after infection with wt Ad2 or mutant 683 
Ad2 ts1. (B) Cytokine induction in cGAS-knockdown MPI cells inoculated with AdGFP or mock 684 
for 16 h.      685 
FIG 4. Ad-induced IL-1 production in MPI cells and BMMs.  (A) Induction of IL-1α and IL-1β 686 
in cell free supernatants of MPI cells and BMMs after Ad infection at the indicated time points. 687 
(B) Western blot analysis of MPI and BMM cell lysates at the indicated time points.  688 
FIG 5. Ad transduction is strongly reduced by blocking MARCO but independent of serum 689 
factors. (A) GFP expression of cells infected with AdGFP in the presence of a MARCO-blocking 690 
(right) or isotype antibody (left). Scale bars indicate 100 µm. Top: fluorescence, bottom: phase 691 
contrast. (B) Cytokine production of AdGFP infected cells without antibody (control), MARCO-692 
blocking antibody or isotype control. (C) GPF expression (upper panel, fluorescence and 693 
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corresponding phase contrast) and IL-6 production (lower panel) of AdGFP infected MPI cells in 694 
the presence or absence of fetal calf serum (FCS). Scale bars indicate 100 µm.  695 
FIG 6. Effect of MARCO and SR-A deficiency on the expression of GFP and IL-6 production in 696 
macrophages infected for 18 h with AdGFP. (A) Fluorescence microscopy (top) and 697 
corresponding phase contrast (bottom) of infected MARCO-/- and wt MPI cells. Scale bars 698 
indicate 50 µm. (B) IL-6 concentration in supernatants of mock-infected and infected MARCO-/-  699 
and wt MPI cells. (C) FACS comparison of MARCO-/- (grey filled histogram) and wt (open 700 
histogram) MPI cells and BMM 16 h after infection with AdGFP. (D) Fluorescence microscopy 701 
(top) and corresponding phase contrast (bottom) of mock-infected and infected AMs from 702 
different knock-out mice. Scale bars indicate 100 µm. (E) IL-6 concentration in supernatants 703 
from mock-infected and infected AMs obtained from different knockout mice. 704 
Fig 7. Peritoneal cells from naive wt and MARCO-/-  mice were infected with AdGFP in vitro. 705 
Left: histograms of peritoneal macrophages 16 h after infection (black: MARCO-/-, red: wt, 706 
dotted: mock , lines: Ad, right: IL-6 induction. 707 
FIG 8. Expression of MARCO in RAW264.7 macrophages increases the infection efficiency and 708 
cytokine response to Ad. (A) Cells infected with AdGFP 16 h after transfection with murine 709 
MARCO or control plasmid DNA. Tomato was used as a reporter for successfully transfected 710 
cells. Cells were analyzed 8 h post infection by FACS. (B) IL-6 was analyzed in cell free 711 
supernatants 8 h after AdGFP infection.   712 
 713 
Supplementary figure legends 714 
 715 
FIG S1.  AdGFP-induced innate immune activation of freshly isolated murine AMs. (A) AM 716 
gating strategy. Living immune cells were identified as DAPI negative, CD45 (pan-immune cell 717 
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marker) expressing BAL cells. AMs were further identified as Siglec F / F4/80 double positive 718 
cells and comprised the large majority of immune cells (> 95 %). AMs highly expressed CD11c 719 
but no CD11b. (B) Activation of p38 and IRF3 was analyzed in whole-cell-lysates by western 720 
blot analysis at the indicated time points.  (C) IFN-α/β and IL-6 were analyzed by ELISA in cell 721 
free supernatants 16 h post infection. 722 
FIG S2. LPS-induced IL-6 production and Ad-induced GFP expression are independent of cGAS. 723 
(A) MPI cells were transduced with cGAS or control shRNA and stimulated with 100 ng/ml LPS. 724 
IL-6 was analyzed in cell free supernatants 16 h after stimulation. (B) GFP expression in MPI 725 
cells infected with AdGFP for 16 h after shRNA mediated knockdown of cGAS (top: 726 
fluorescence; bottom: corresponding phase contrast, Scale bars indicate 100 µm).  727 
FIG S3. CAR, SREC1, SR-A and MARCO expression in BMM and MPI cells. (A) Comparison 728 
of mRNA expression (normalized intensity values; NI) in BMM and MPI cells using microarray 729 
data published in (1). 730 
(B) mRNA expression of indicated genes validated by qRT-PCR. Lung and B cell total RNA was 731 
used as positive and negative control, respectively. n. d.: not detectable (C) FACS analysis of SR-732 
A and MARCO expression in BMM and MPI cells . Open histograms: specific antibody, grey 733 
filled histograms: isotype control. 734 
FIG S4. MARCO expression of different tissue macrophages. Macrophages were analyzed 735 
immediately after digestion (liver, skin, spleen) or lavage (peritoneum, lung) without prior 736 
enrichment by selective adhesion. 737 
FIG S5. Surface protein expression and innate responsiveness of wt and MARCO-/- MPI cells and 738 
AM. (A) FACS analysis with anti-CD11b, -CD14, -MARCO, -Siglec F, -F4/80 and -CD11c. 739 
Open black histograms: wt cells, open red histograms: MARCO-/- cells, grey filled histograms: 740 
isotype control (B) IL-6 production in cell free supernatants  of MPI cells 16 h after stimulation 741 
 36 
with FSL-1 or LPS. (C) FACS analysis of BAL cells from naive wt and MARCO-/- mice. AMs 742 
were identified as Siglec F / F4/80 double positive cells as shown in Fig S1A and AM number is 743 
given as frequency of CD45 (pan-immune cell marker) positive  BAL cells. AMs were FACS 744 
analyzed with anti-CD11b, -CD14, -Siglec F, -F4/80 and -CD11c. Open, black histograms: wt 745 
cells, open red histograms: MARCO-/- cells, grey filled histograms: isotype control (D) IL-6 746 
production in cell free supernatants of AMs  16 h after stimulation with 100 ng/ml LPS. 747 
FIG S6. Analysis of transfected RAW264.7 cells. (A) FACS analysis of RAW264.7 cells 748 
transfected with MARCO/tomato- or tomato-expressing plasmids. FACS analysis with anti-749 
MARCO was performed 16 h after transfection. Left: Frequencies of tomato+ cells. Right: 750 
MARCO staining on tomato+ (top) or tomato- (bottom) cell populations (open histogram: 751 
tomato-transfected cells, grey filled histogram: MARCO/tomato -transfected cells). (B) Scatter 752 
dot plot of linear regression of AdGFP infected MARCO or control transfected RAW264.7 cells. 753 
 754 
Supplementary references 755 
 756 
1.   Fejer G, Wegner MD, Györy I, Cohen I, Engelhard P, Voronov E, Manke T, Ruzsics Z, 757 
Dölken L, da Costa OP. 2013. Nontransformed, GM-CSF–dependent macrophage lines 758 
are a unique model to study tissue macrophage functions. Proceedings of the National 759 
Academy of Sciences 110:E2191-E2198. 760 
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FIG	   1.	   Eﬃciency	   of	   Ad	   infec3on	   in	   diﬀerent	   cell	   types.	   (A)	   GFP	   expression	   was	   analyzed	   in	  
diﬀerent	   cell	   types	   16	   h	   aCer	   infec3on	  with	   AdGFP	   using	   ﬂuorescence	   (top)	   and	   light	   (phase	  
contrast;	   boIom)	   microscopy.	   Bars	   indicate	   50	   µm.	   (B)	   FACS	   analysis	   of	   GFP	   expression	   in	  
infected	  cells	  at	  the	  indicated	  3me	  points.	  The	  number	  indicates	  the	  frequency	  of	  GFP+	  cells	  16	  h	  
aCer	  infec3on,	  the	  gate	  indicates	  GFP+	  cells.	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FIG	  2.	   Early	   immune	  ac2va2on	  of	  MPI	   cells	   and	  BMMs	  a;er	   infec2on	  with	  AdGFP.	   (A)	  
Western	   blot	   analysis	   of	   the	   cytoplasmic	   (p-­‐p38,	   p-­‐IRF3)	   or	   nuclear	   (NF-­‐kB	   p65)	   cell	  
frac2ons	  at	  the	  indicated	  2me	  points.	  (B)	  Cytokine	  produc2on	  was	  measured	  by	  ELISA	  in	  
cell	  free	  supernatants	  at	  the	  indicated	  2me	  points.	  
B A 
wt TLR2/4-/- 
FIG	  3.	  Ad-­‐induced	  cytokine	  produc5on	  in	  MPI	  cells	  is	  independent	  of	  TLR2/4	  but	  dependent	  
on	  cGAS.	  (A)	  IL-­‐6	  induc5on	  in	  wt	  and	  TLR2/4-­‐/-­‐	  MPI	  cells	  aHer	  infec5on	  with	  wt	  Ad2	  or	  mutant	  
Ad2	  ts1.	  (B)	  Cytokine	  induc5on	  in	  cGAS-­‐knockdown	  MPI	  cells	  inoculated	  with	  AdGFP	  or	  mock	  
for	  16	  h.	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FIG	  4.	  Ad-­‐induced	  IL-­‐1	  produc4on	  in	  MPI	  cells	  and	  BMMs.	  	  (A)	  Induc4on	  of	  IL-­‐1α	  and	  IL-­‐1β	  in	  cell	  free	  
supernatants	  of	  MPI	  cells	  and	  BMMs	  aAer	  Ad	  infec4on	  at	  the	  indicated	  4me	  points.	  (B)	  Western	  blot	  
analysis	  of	  MPI	  and	  BMM	  cell	  lysates	  at	  the	  indicated	  4me	  points.	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FIG	   5.	   Ad	   transduc0on	   is	   strongly	   reduced	   by	   blocking	  MARCO	   but	   independent	   of	   serum	  
factors.	  (A)	  GFP	  expression	  of	  cells	  infected	  with	  AdGFP	  in	  the	  presence	  of	  a	  MARCO-­‐blocking	  
(right)	  or	  isotype	  an0body	  (leG).	  Scale	  bars	  indicate	  100	  µm.	  Top:	  ﬂuorescence,	  boPom:	  phase	  
contrast.	  (B)	  Cytokine	  produc0on	  of	  AdGFP	  infected	  cells	  without	  an0body	  (control),	  MARCO-­‐
blocking	   an0body	   or	   isotype	   control.	   (C)	   GPF	   expression	   (upper	   panel,	   ﬂuorescence	   and	  
corresponding	  phase	  contrast)	  and	  IL-­‐6	  produc0on	  (lower	  panel)	  of	  AdGFP	  infected	  MPI	  cells	  
in	  the	  presence	  or	  absence	  of	  fetal	  calf	  serum	  (FCS).	  Scale	  bars	  indicate	  100	  µm.	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FIG	   6.	   Eﬀect	   of	   MARCO	   and	   SR-­‐A	   deﬁciency	   on	   the	   expression	   of	   GFP	   and	   IL-­‐6	   producCon	   in	  
macrophages	  infected	  for	  18	  h	  with	  AdGFP.	  (A)	  Fluorescence	  microscopy	  (top)	  and	  corresponding	  
phase	  contrast	  (boMom)	  of	  infected	  MARCO-­‐/-­‐	  and	  wt	  MPI	  cells.	  Scale	  bars	  indicate	  50	  µm.	  (B)	  IL-­‐6	  
concentraCon	  in	  supernatants	  of	  mock-­‐infected	  and	  infected	  MARCO-­‐/-­‐	  	  and	  wt	  MPI	  cells.	  (C)	  FACS	  
comparison	  of	  MARCO-­‐/-­‐	  (grey	  ﬁlled	  histogram)	  and	  wt	  (open	  histogram)	  MPI	  cells	  and	  BMM	  16	  h	  
aTer	  infecCon	  with	  AdGFP.	  (D)	  Fluorescence	  microscopy	  (top)	  and	  corresponding	  phase	  contrast	  
(boMom)	  of	  mock-­‐infected	  and	   infected	  AMs	   from	  diﬀerent	   knock-­‐out	  mice.	   Scale	  bars	   indicate	  
100	  µm.	   (E)	   IL-­‐6	   concentraCon	   in	   supernatants	   from	  mock-­‐infected	   and	   infected	  AMs	  obtained	  
from	  diﬀerent	  knockout	  mice.	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FIG 7. Peritoneal cells from naive wt and MARCO-/-  mice were infected with AdGFP 
in vitro. Left: histograms of peritoneal macrophages 16 h after infection (black: 
MARCO-/-, red: wt, dotted: mock , lines: Ad, right: IL-6 induction 
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FIG	   8.	   Expression	   of	  MARCO	   in	   RAW264.7	  macrophages	   increases	   the	   infecAon	   eﬃciency	   and	  
cytokine	   response	   to	   Ad.	   (A)	   Cells	   infected	   with	   AdGFP	   16	   h	   aLer	   transfecAon	   with	   murine	  
MARCO	  or	  control	  plasmid	  DNA.	  Tomato	  was	  used	  as	  a	  reporter	  for	  successfully	  transfected	  cells.	  
Cells	  were	  analyzed	  8	  h	  post	  infecAon	  by	  FACS.	  (B)	  IL-­‐6	  was	  analyzed	  in	  cell	  free	  supernatants	  8	  h	  
aLer	  AdGFP	  infecAon.	  	  	  
B 
FIG	   S1.	   	   AdGFP-­‐induced	   innate	   immune	   ac4va4on	   of	   freshly	   isolated	  murine	   AMs.	   (A)	   AM	   ga4ng	  
strategy.	   Living	   immune	   cells	   were	   iden4ﬁed	   as	   DAPI	   nega4ve,	   CD45	   (pan-­‐immune	   cell	   marker)	  
expressing	   BAL	   cells.	   AMs	   were	   further	   iden4ﬁed	   as	   Siglec	   F	   /	   F4/80	   double	   posi4ve	   cells	   and	  
comprised	  the	  large	  majority	  of	   immune	  cells	  (>	  95	  %).	  AMs	  highly	  expressed	  CD11c	  but	  no	  CD11b.	  
boUom:	  comparison	  of	  AM	  frequency	  before	  and	  aWer	  selec4ve	  adhesion.	  (B)	  Ac4va4on	  of	  p38	  and	  
IRF3	  was	  analyzed	  in	  whole-­‐cell-­‐lysates	  by	  western	  blot	  analysis	  at	  the	  indicated	  4me	  points.	  	  (C)	  IFN-­‐
α/β	  and	  IL-­‐6	  were	  analyzed	  by	  ELISA	  in	  cell	  free	  supernatants	  16	  h	  post	  infec4on.	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FIG S2. LPS-induced IL-6 production and Ad-induced GFP expression are 
independent of cGAS. (A) MPI cells were transduced with cGAS or control 
shRNA and stimulated with 100 ng/ml LPS. IL-6 was analyzed in cell free 
supernatants 16 h after stimulation. (B) GFP expression in MPI cells infected with 
AdGFP for 16 h after shRNA mediated knockdown of cGAS (top: fluorescence; 
bottom: corresponding phase contrast, Scale bars indicate 100 µm).  
FIG S3. CAR, SREC1, SR-A and MARCO expression in BMM and MPI cells. (A) 
Comparison of mRNA expression (normalized intensity values; NI) in BMM and MPI 
cells using microarray data published in (1). 
(B) mRNA expression of indicated genes validated by qRT-PCR. Lung and B cell total 
RNA was used as positive and negative control, respectively. n. d.: not detectable (C) 
FACS analysis of SR-A and MARCO expression in BMM and MPI cells . Open 
histograms: specific antibody, grey filled histograms: isotype control 
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FIG S4. MARCO expression of different tissue macrophages. Macrophages were 
analyzed immediately after digestion (liver, skin, spleen) or lavage (peritoneum, lung) 
without prior enrichment by selective adhesion. 
A B 
FIG S5. Surface protein expression and innate responsiveness of wt and MARCO-/- MPI 
cells and AM. (A) FACS analysis with anti-CD11b, -CD14, -MARCO, -Siglec F, -F4/80 and -
CD11c. Open black histograms: wt cells, open red histograms: MARCO-/- cells, grey filled 
histograms: isotype control (B) IL-6 production in cell free supernatants  of MPI cells 16 h 
after stimulation with FSL-1 or LPS. (C) FACS analysis of BAL cells from naïve wt and 
MARCO-/- mice. AMs were identified as Siglec F / F4/80 double positive cells as shown in 
Fig S1A and AM number is given as frequency of CD45 (pan-immune cell marker) positive  
BAL cells. AMs were FACS analyzed with anti-CD11b, -CD14, -Siglec F, -F4/80 and -
CD11c. Open, black histograms: wt cells, open red histograms: MARCO-/- cells, grey filled 
histograms: isotype control (D) IL-6 production in cell free supernatants of AMs  16 h after 
stimulation with 100 ng/ml LPS.         
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FIG S6. Analysis of transfected RAW264.7 cells. (A) FACS analysis of RAW264.7 cells 
transfected with MARCO/tomato- or tomato-expressing plasmids. FACS analysis with 
anti-MARCO was performed 16 h after transfection. Left: Frequencies of tomato+ cells. 
Right: MARCO staining on tomato+ (top) or tomato- (bottom) cell populations (open 
histogram: tomato-transfected cells, grey filled histogram: MARCO/tomato -transfected 
cells). (B) Scatter dot plot of linear regression of AdGFP infected MARCO or control 
transfected RAW264.7 cells. 
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